It's great to hear you're currently in remission! The question of whether an allogeneic stem cell transplant (alloSCT) makes sense while in remission from PTCL-NOS is an important one to explore with your oncologist.
An alloSCT uses stem cells from a donor to help replace lymphoma cells. It can be considered as a treatment Show Full Answer
It's great to hear you're currently in remission! The question of whether an allogeneic stem cell transplant (alloSCT) makes sense while in remission from PTCL-NOS is an important one to explore with your oncologist.
An alloSCT uses stem cells from a donor to help replace lymphoma cells. It can be considered as a treatment option for certain types of T-cell lymphoma, including PTCL-NOS, particularly to:
- Help prevent relapse after achieving remission
- Treat cases where the cancer has come back or become resistant to treatment
The timing of a transplant — whether during remission or after relapse — is something doctors weigh carefully based on individual factors. There are some important risks to be aware of with an alloSCT:
- Graft-versus-host disease (GVHD) — where the donor's immune cells may attack your healthy tissues or organs
- Finding a closely matched donor is critical to reducing this risk
- AlloSCTs are generally considered riskier than autologous transplants (using your own cells)
Because PTCL-NOS has a higher risk of relapse, some doctors do recommend consolidating remission with a transplant. This is a very personal decision, so a detailed conversation with your oncologist or a transplant specialist is strongly encouraged.
September 9
Join
Your Privacy Choices
